Thalia Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5	4	2	2	4	8
Market Cap Growth	73.33%	110.82%	-9.28%	-47.17%	-46.33%	-46.71%
Enterprise Value	4	3	1	1	3	6
Last Close Price	0.01	0.01	0.01	0.01	0.02	0.04
PS Ratio	744.74	601.52	284.62	1169.81	-	-
PB Ratio	5.05	4.08	3.18	1.91	2.07	3.78
P/TBV Ratio	5.06	4.08	3.20	2.14	2.07	3.78
EV/Sales Ratio	-	363.80	123.16	509.40	-	-
Net Debt / Equity Ratio	-1.01	-1.01	-0.96	-0.86	-0.92	-0.84
Asset Turnover	0.01	0.01	0.01	0.00	-	-
Quick Ratio	11.77	11.77	6.12	14.73	27.34	10.98
Current Ratio	11.93	11.93	6.24	14.86	27.81	11.01
Return on Equity (ROE)	-140.32%	-140.32%	-121.41%	-77.81%	-48.80%	-53.37%
Return on Assets (ROA)	-74.91%	-74.91%	-74.42%	-48.50%	-33.08%	-37.35%
Return on Capital Employed (ROCE)	-108.80%	-108.80%	-187.50%	-111.90%	-57.10%	-86.60%
Earnings Yield	-22.27%	-27.58%	-51.08%	-55.56%	-23.80%	-19.16%
Buyback Yield / Dilution	-112.51%	-112.51%	-40.34%	-30.29%	-2.95%	-32.85%